Our findings demonstrated that UBA7 downregulation in SF3B1-mutant CLL is strongly linked to poor survival, suggesting its potential integration into prognostic models to enhance the prediction of disease progression. The gene discussed is SF3B1; the disease is B-cell chronic lymphocytic leukemia.